全文获取类型
收费全文 | 1297480篇 |
免费 | 94589篇 |
国内免费 | 2019篇 |
专业分类
耳鼻咽喉 | 18503篇 |
儿科学 | 43159篇 |
妇产科学 | 38219篇 |
基础医学 | 189537篇 |
口腔科学 | 35832篇 |
临床医学 | 109530篇 |
内科学 | 257111篇 |
皮肤病学 | 27260篇 |
神经病学 | 101064篇 |
特种医学 | 50616篇 |
外国民族医学 | 366篇 |
外科学 | 200713篇 |
综合类 | 26609篇 |
现状与发展 | 1篇 |
一般理论 | 302篇 |
预防医学 | 94540篇 |
眼科学 | 29462篇 |
药学 | 98889篇 |
1篇 | |
中国医学 | 2570篇 |
肿瘤学 | 69804篇 |
出版年
2018年 | 12702篇 |
2016年 | 10482篇 |
2015年 | 12049篇 |
2014年 | 16502篇 |
2013年 | 25170篇 |
2012年 | 35000篇 |
2011年 | 37540篇 |
2010年 | 22046篇 |
2009年 | 20650篇 |
2008年 | 36310篇 |
2007年 | 39335篇 |
2006年 | 39853篇 |
2005年 | 39138篇 |
2004年 | 37633篇 |
2003年 | 36535篇 |
2002年 | 36057篇 |
2001年 | 58857篇 |
2000年 | 60541篇 |
1999年 | 51361篇 |
1998年 | 14339篇 |
1997年 | 12872篇 |
1996年 | 13146篇 |
1995年 | 12392篇 |
1994年 | 11791篇 |
1993年 | 10897篇 |
1992年 | 41227篇 |
1991年 | 40536篇 |
1990年 | 40075篇 |
1989年 | 38830篇 |
1988年 | 36217篇 |
1987年 | 35446篇 |
1986年 | 33820篇 |
1985年 | 32206篇 |
1984年 | 23970篇 |
1983年 | 20860篇 |
1982年 | 12393篇 |
1981年 | 10940篇 |
1979年 | 22663篇 |
1978年 | 15891篇 |
1977年 | 13749篇 |
1976年 | 12993篇 |
1975年 | 14227篇 |
1974年 | 16721篇 |
1973年 | 16112篇 |
1972年 | 15351篇 |
1971年 | 14260篇 |
1970年 | 13244篇 |
1969年 | 12766篇 |
1968年 | 12000篇 |
1967年 | 10493篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
4.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
5.
6.
7.
8.
Madan M. Rehani Emily R. Melick Raza M. Alvi Ruhani Doda Khera Salma Batool-Anwar Tomas G. Neilan Michael Bettmann 《European radiology》2020,30(4):1839-1846
To determine percent of patients without malignancy and ≤ 40 years of age with high cumulative radiation doses through recurrent CT exams and assess imaging appropriateness. From the cohort of patients who received cumulative effective dose (CED) of ≥ 100 mSv over a 5-year period, a sub-set was identified with non-malignant disease. The top 50 clinical indications leading to multiple CTs were determined. Clinical decision support (CDS) system scores were analyzed using a widely adopted standard of 1–3 (red) as “not usually appropriate,” 4–6 (yellow) “may or may not be appropriate,” and 7–9 (green) “usually appropriate.” Clinicians reviewed patient records to assess compliance with appropriate use criteria (AUC). 9.6% of patients in our series were with non-malignant conditions and 1.4% with age ≤ 40 years. CDS scores (rounded) were 2% red, 38% yellow, 27% green, and 33% unscored CTs. Clinical society guidelines for CT exams, wherever available, were followed in 87.5 to 100% of cases. AUCs were not available for several clinical indications as also referral guidelines for serial CT imaging. More than half of CT exams were unrelated to follow-up of a primary chronic disease. We are faced with a situation wherein patients in age ≤ 40 years require or are thought to require many CT exams over the course of a few years but the radiation risk creates concern. There is a fair number of conditions for which AUC are not available. Suggested solutions include development of CT scanners with lesser radiation dose and further development of appropriateness criteria. 相似文献
9.
10.
Ali Mobasheri Csaba Matta Ilona Uzielienè Emma Budd Pablo Martín-Vasallo Eiva Bernotiene 《Joint, bone, spine : revue du rhumatisme》2019,86(1):29-35
Chondrocytes are the main cells in the extracellular matrix (ECM) of articular cartilage and possess a highly differentiated phenotype that is the hallmark of the unique physiological functions of this specialised load-bearing connective tissue. The plasma membrane of articular chondrocytes contains a rich and diverse complement of membrane proteins, known as the membranome, which defines the cell surface phenotype of the cells. The membranome is a key target of pharmacological agents and is important for chondrocyte function. It includes channels, transporters, enzymes, receptors, and anchors for intracellular, cytoskeletal and ECM proteins and other macromolecular complexes. The chondrocyte channelome is a sub-compartment of the membranome and includes a complete set of ion channels and porins expressed in these cells. Many of these are multi-functional proteins with “moonlighting” roles, serving as channels, receptors and signalling components of larger molecular assemblies. The aim of this review is to summarise our current knowledge of the fundamental aspects of the chondrocyte channelome, discuss its relevance to cartilage biology and highlight its possible role in the pathogenesis of osteoarthritis (OA). Excessive and inappropriate mechanical loads, an inflammatory micro-environment, alternative splicing of channel components or accumulation of basic calcium phosphate crystals can result in an altered chondrocyte channelome impairing its function. Alterations in Ca2+ signalling may lead to defective synthesis of ECM macromolecules and aggravated catabolic responses in chondrocytes, which is an important and relatively unexplored aspect of the complex and poorly understood mechanism of OA development. 相似文献